BTBBCL6 dimers as building blocks for reversible drug-induced protein oligomerization.
Saved in:
| Title: | BTB |
|---|---|
| Authors: | Nitsch L; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Jensen P; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Yoon H; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Koeppel J; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Burman SSR; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Scholl C; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany., Słabicki M; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. |
| Source: | Cell reports methods [Cell Rep Methods] 2022 Apr 13; Vol. 2 (4), pp. 100193. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-2375 (Electronic) Linking ISSN: 26672375 NLM ISO Abbreviation: Cell Rep Methods |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35497498 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BTB<subscript>BCL6</subscript> dimers as building blocks for reversible drug-induced protein oligomerization. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nitsch+L%22">Nitsch L</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jensen+P%22">Jensen P</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Yoon+H%22">Yoon H</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Koeppel+J%22">Koeppel J</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Burman+SSR%22">Burman SSR</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Fischer+ES%22">Fischer ES</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Scholl+C%22">Scholl C</searchLink>; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fröhling+S%22">Fröhling S</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Słabicki+M%22">Słabicki M</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918227360606676%22">Cell reports methods</searchLink> [Cell Rep Methods] 2022 Apr 13; Vol. 2 (4), pp. 100193. <i>Date of Electronic Publication: </i>2022 Apr 13 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918227360606676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2667-2375 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226672375%22">26672375 </searchLink><i>NLM ISO Abbreviation: </i>Cell Rep Methods |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35497498 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.crmeth.2022.100193 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100193 Titles: – TitleFull: BTBBCL6 dimers as building blocks for reversible drug-induced protein oligomerization. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nitsch L – PersonEntity: Name: NameFull: Jensen P – PersonEntity: Name: NameFull: Yoon H – PersonEntity: Name: NameFull: Koeppel J – PersonEntity: Name: NameFull: Burman SSR – PersonEntity: Name: NameFull: Fischer ES – PersonEntity: Name: NameFull: Scholl C – PersonEntity: Name: NameFull: Fröhling S – PersonEntity: Name: NameFull: Słabicki M IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 04 Text: 2022 Apr 13 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2667-2375 Numbering: – Type: volume Value: 2 – Type: issue Value: 4 Titles: – TitleFull: Cell reports methods Type: main |
| ResultId | 1 |